Compare Novavax Inc (NVAX) vs Constellation Brands Inc. Common Stock (STZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Constellation Brands Inc. Common Stock — how do they compare? Novavax Inc trades at $12.41 (market cap $2.08B), while Constellation Brands Inc. Common Stock trades at $128.99 (market cap $21.56B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 10.4× Novavax Inc's market cap, and Constellation Brands Inc. Common Stock pays a 3.23% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | STZ | |
|---|---|---|
Market Cap | $2.08B | $21.56B |
Volume | 8,501,139 | 1,626,934 |
Sector | Health | Consumer Staples |
52-Week High | $12.82 | $166.68 |
52-Week Low | $6.22 | $112.77 |
Typical Hold Time | 59 Days | — |
Enterprise Value | $1.66B | $31.78B |
Dividend Yield | — | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $12.82, up 1.26% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and strategic pivots toward its Matrix-M adjuvant platform and partnerships, such as with Sanofi for COVID-19 vaccines, highlight operational progress. However, negative cash flows and a net loss in 2026 projections underscore financial volatility amid transitioning revenue streams.
The outlook balances near-term catalysts from vaccine approvals and partnership momentum against persistent cash burn and competitive pressures. Investors face opportunity in undervalued metrics like a low P/E of 3.14, but risks include execution hurdles and dependency on successful licensing deals to achieve sustainable profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Constellation Brands Inc. Common Stock
Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →
